Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system
The SURPASS program (for type 2 diabetes) and SURMOUNT program (for obesity) together enrolled over 20,000 participants across multiple Phase III trials
HDAC inhibitory and anti-cancer activities of curcumin and curcumin derivative CU17 against human lung cancer A549 cells
Andreeff M , Konopleva M, Watt JC, Samudio IJ, Satterthwait AC, Kitada S, Zhang X, Reed JC
From our curated wellness programs to our state-of-the-art amenities, Eden is where your best self begins
We will examine how it works within the body, why its impact on the vascular system is significant, and why the way you take this supplement determines whether your body can actually use it